State LA
Clinical Trials in Louisiana
Recruiting clinical trials with at least one study location in Louisiana. Data updated daily from ClinicalTrials.gov.
Top Conditions in Louisiana
Peripheral Artery Disease (3)Chronic Lymphocytic Leukemia (3)Asthma (2)Hypertension (2)Small Lymphocytic Lymphoma (2)Endometrial Cancer (2)Anatomic Stage II Breast Cancer AJCC v8 (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Idiopathic Short Stature (2)Acute Myeloid Leukemia (2)Obesity (2)
Frequently Asked Questions — Clinical Trials in Louisiana
How many clinical trials are currently recruiting in Louisiana?
ClinicalMetric currently tracks 125 actively recruiting clinical trials with at least one location in Louisiana. The total number of registered studies—including active but not currently enrolling trials—is 125. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Louisiana?
Louisiana hosts clinical trials across a broad range of medical conditions, including Peripheral Artery Disease, Chronic Lymphocytic Leukemia, Asthma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Louisiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Louisiana?
To join a clinical trial in Louisiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Louisiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Louisiana
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06578247 Phase 3
Recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-I...
Condition
Leukemia
Enrollment
700 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
NCT05135091 Phase 3
Recruiting
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Tempo...
Condition
Mesial Temporal Lobe Epilepsy
Enrollment
88 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04566328 Phase 3
Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Mu...
Condition
Plasma Cell Myeloma
Enrollment
1,450 pts
Location
United States, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05848739 Phase 1
Recruiting
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tu...
Condition
Colon Cancer
Enrollment
130 pts
Location
United States
Sponsor
Sapience Therapeutics
NCT07290179 N/A
Recruiting
Evaluating the Validity and Feasibility of a Smartwatch-based Eating Detection S...
Condition
Eating Behavior
Enrollment
35 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT05639465 N/A
Recruiting
Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Child...
Condition
Emotional Distress
Enrollment
800 pts
Location
United States
Sponsor
University of Illinois at Urba
NCT05855200 Phase 3
Recruiting
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage ...
Condition
Colonic Neoplasms
Enrollment
892 pts
Location
United States, Argentina, Australia
Sponsor
GlaxoSmithKline
NCT07221851 Phase 3
Recruiting
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared...
Condition
Turner Syndrome
Enrollment
186 pts
Location
United States, Spain
Sponsor
Ascendis Pharma A/S
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05517967 N/A
Recruiting
An Examination of Brown Adipose Tissue and Energy Expenditure in Infants
Condition
Cold Induced Thermogenesis
Enrollment
60 pts
Location
United States
Sponsor
Pennington Biomedical Research
NCT06680830 Phase 2
Recruiting
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Posi...
Condition
Parkinson Disease
Enrollment
150 pts
Location
United States, Israel, Italy
Sponsor
Neuron23 Inc.
NCT06588855 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Ulcerative Colitis
Enrollment
350 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT07398417 Phase 3
Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal ...
Condition
Fibromyalgia
Enrollment
620 pts
Location
United States
Sponsor
Axsome Therapeutics, Inc.
NCT06906185 N/A
Recruiting
Adaptation and Examination of a Trauma-informed Intervention for Pregnant Vetera...
Condition
Trauma-related Mental Health Symptoms
Enrollment
36 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT07392190 Phase 3
Recruiting
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who ...
Condition
Overweight
Enrollment
900 pts
Location
United States, Australia, Belgium
Sponsor
Eli Lilly and Company
NCT06172296 Phase 3
Recruiting
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Tre...
Condition
Ganglioneuroblastoma, Nodular
Enrollment
478 pts
Location
United States, Australia, Canada
Sponsor
National Cancer Institute (NCI
NCT05946213 Phase 3
Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in...
Condition
Prostate Adenocarcinoma
Enrollment
1,209 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Ca...
Condition
Prostate Cancer (Adenocarcinoma)
Enrollment
830 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT07039396 N/A
Recruiting
Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for ...
Condition
Diabetic Foot Ulcer
Enrollment
10 pts
Location
United States
Sponsor
NuScience Medical Biologics, L
NCT03911700 N/A
Recruiting
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
Condition
Open Midline Laparotomy
Enrollment
477 pts
Location
United States, Austria, Belgium
Sponsor
C. R. Bard
NCT03331198 Phase 1, Phase 2
Recruiting
Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Ref...
Condition
Leukemia, Lymphocytic, Chronic, B-Cell
Enrollment
320 pts
Location
United States, Canada
Sponsor
Juno Therapeutics, a Subsidiar
NCT05156398 Phase 3
Recruiting
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migrai...
Condition
Migraine
Enrollment
640 pts
Location
United States, Canada, France
Sponsor
Pfizer
NCT06291376 Phase 3
Recruiting
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
Condition
Immunoglobulin A Nephropathy
Enrollment
510 pts
Location
United States, Argentina, Australia
Sponsor
Alexion Pharmaceuticals, Inc.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology